J&J Is in Talks to Buy $10 Billion Biotech Intra-Cellular

2025-01-13 12:30:02

added new post

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system...

0 Comments 0 Shares